FMP
Aug 2, 2022 10:39 AM - Davit Kirakosyan(Last modified: Dec 19, 2023 5:49 PM)
Church & Dwight Co., Inc. (NYSE:CHD) shares dropped nearly 8% since the Q2 earnings announcement last week. EPS came in at $0.76, better than the Street estimate of $0.72. Revenue was $1.33 billion, compared to the Street estimate of $1.34 billion.
Analysts at Deutsche Bank provided their key takeaways from the results. Although they acknowledge a challenging operating environment amidst cost inflation and broad-based supply chain bottlenecks, the analysts noted the results and updated guidance were disappointing.
While the EPS came in better than expected, the analysts mentioned that this could be primarily attributed to significantly lower marketing spend (approximately 18% lower than consensus), as company organic growth of 3.4% missed the consensus estimate of 3.7%.
More critically, higher costs and lost revenue from demand headwinds in discretionary categories (Waterpik, Flawless) caused the company to materially reduce its full-year EPS estimates for 2022 to around $3.02 from the low-end of $3.14-$3.26 prior.
The analysts lowered their price target on the company’s shares to $93 from $99, while maintaining their hold rating.
Oct 31, 2023 8:03 AM - Parth Sanghvi
Free cash flow to the firm (FCFF) and free cash flow to equity (FCFE) are two of the most important metrics used in financial modeling. Both metrics measure the amount of cash that is available to a company's shareholders and creditors, but there is a key difference between the two. FCFF measures...
Nov 25, 2023 6:39 AM - Parth Sanghvi
Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...
Dec 23, 2023 2:19 AM - Parth Sanghvi
Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...